Curr Diabetes Rev 19:3145 Gejl M, Gjedde A, Egefjord L et al (2016) In Alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
In Which Age Range Is It Seen
The bigger challenge isn't just helping people lose weight
In addition to gluten-containing foods, certain chemicals and medications can also bring on symptoms in people with this condition
Oral, BBB-penetrant delivery: The medicinal-chemistry program characterized Dihexa as metabolically stable and orally active enough to reach the brain in animals the property that distinguished it from earlier AngIV peptides [1]
Does it have side effects, warnings or interactions